13-azaprostanoic acid has been researched along with dinoprost in 3 studies
| Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
|---|---|---|---|---|---|
| 42 | 0 | 0 | 11,554 | 940 | 1,936 |
| Protein | Taxonomy | 13-azaprostanoic acid (IC50) | dinoprost (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuo, K; Imanaka, S; Koh, E; Kumahara, Y; Morimoto, S; Onishi, T; Tsuchiya, H; Yamamoto, H; Yukawa, S | 1 |
| Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G | 1 |
| Ishikawa, M; Namiki, A | 1 |
3 other study(ies) available for 13-azaprostanoic acid and dinoprost
| Article | Year |
|---|---|
Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Benzofurans; Calcium; Dinoprost; Female; Fura-2; Muscle, Smooth, Vascular; Prostaglandins; Prostaglandins F; Prostanoic Acids; Rats; Rats, Inbred Strains; Thromboxane A2; Time Factors | 1986 |
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase | 1985 |
The contractile mechanism of beraprost sodium, a stable prostacyclin analog, in the isolated canine femoral vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Dinoprost; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Female; Femoral Artery; Femoral Vein; In Vitro Techniques; Male; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |